Author’s Accepted Manuscript Genetic Testing for CYP2D6 and CYP2C19 Suggests Improved Outcome for Antidepressant and Antipsychotic Medication Lucas M. Walden, Eva J. Brandl, Arun K. Tiwari, Sheraz Cheema, Natalie Freeman, Nicole Braganza, James L. Kennedy, Daniel J. Müller PII: S0165-1781(17)31330-6 DOI: https://doi.org/10.1016/j.psychres.2018.02.055 Reference: PSY11229 To appear in: Psychiatry Research Received date: 7 August 2017 Revised date: 22 January 2018 Accepted date: 27 February 2018 Cite this article as: Lucas M. Walden, Eva J. Brandl, Arun K. Tiwari, Sheraz Cheema, Natalie Freeman, Nicole Braganza, James L. Kennedy and Daniel J. Müller, Genetic Testing for CYP2D6 and CYP2C19 Suggests Improved Outcome for Antidepressant and Antipsychotic Medication, Psychiatry Research, https://doi.org/10.1016/j.psychres.2018.02.055 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting galley proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. www.elsevier.com/locate/psychres